{
    "id": 7852,
    "fullName": "MSH6 loss",
    "impact": "unknown",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "MSH6 loss indicates loss of the MSH6 gene, mRNA, and protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 2956,
        "geneSymbol": "MSH6",
        "terms": [
            "MSH6",
            "GTBP",
            "GTMBP",
            "HNPCC5",
            "HSAP",
            "p160"
        ]
    },
    "variant": "loss",
    "createDate": "06/19/2015",
    "updateDate": "10/02/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2456,
            "approvalStatus": "Preclinical",
            "evidenceType": "Emerging",
            "efficacyEvidence": "Preclinical shRNA mediated-inhibition of PTEN-induced putative kinase 1 (PINK1) in colon carcinoma cells with MSH6 loss resulted in synthetic lethality, suggesting PINK1 may be a promising therapeutic target for MSH6 deficient cancer cells (PMID: 21242281).",
            "molecularProfile": {
                "id": 7744,
                "profileName": "MSH6 loss"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 1520,
                "name": "colon carcinoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 3097,
                    "pubMedId": 21242281,
                    "title": "Parallel high-throughput RNA interference screens identify PINK1 as a potential therapeutic target for the treatment of DNA mismatch repair-deficient cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21242281"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 11384,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MSH6 deficient colon cancer cells did not respond to treatment with KU60648 in culture (PMID: 28224663).",
            "molecularProfile": {
                "id": 7744,
                "profileName": "MSH6 loss"
            },
            "therapy": {
                "id": 5967,
                "therapyName": "KU60648",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 9237,
                    "pubMedId": 28224663,
                    "title": "Loss of MLH1 sensitizes colon cancer cells to DNA-PKcs inhibitor KU60648.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28224663"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 7744,
            "profileName": "MSH6 loss",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}